INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹1.22 Cr | ₹6.29 Cr | ₹2.41 Cr | ₹1.46 Cr | ₹1.53 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDO US BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹1.22 Cr |
Mar2023 | ₹6.29 Cr |
Mar2022 | ₹2.41 Cr |
Mar2021 | ₹1.46 Cr |
Mar2020 | ₹1.53 Cr |
How is Cash Flow from Financing Activities of INDO US BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1.22 Cr | -80.68 | |
Mar2023 | ₹6.29 Cr | 160.95 | |
Mar2022 | ₹2.41 Cr | 64.96 | |
Mar2021 | ₹1.46 Cr | -4.38 | |
Mar2020 | ₹1.53 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹299.2 Cr | -0.5% | -12.2% | -45.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,467.5 Cr | -0.8% | -7.7% | -31.8% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,108.9 Cr | 3% | 5.2% | 10.1% | Stock Analytics | |
VENKYS (INDIA) | ₹2,060.3 Cr | -2.1% | -2.8% | -36.6% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,467.0 Cr | -1.9% | 0.1% | -26.8% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹518.1 Cr | -0.6% | -10.3% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -0.5% |
-12.2% |
-45.8% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses